Fineline Cube

Follow:
14486 Articles
Kelun-Biotech's Trastuzumab Botidotin HER2 ADC Launches in China After Phase 3 Win vs T-DM1
CompanyDrug

Kelun-Biotech’s Trastuzumab Botidotin HER2 ADC Launches in China After Phase 3 Win vs T-DM1

Regeneron's Libtayo Wins EC Approval for Adjuvant CSCC, 68% Risk Reduction
CompanyDrug

Regeneron’s Libtayo Wins EC Approval for Adjuvant CSCC, 68% Risk Reduction

Novartis Builds $23B North Carolina Manufacturing Hub, Adding 700 Jobs
Company

Novartis Builds $23B North Carolina Manufacturing Hub, Adding 700 Jobs

Lynk's LNK01004 Pan-JAK Inhibitor Shows EASI-75 Win in Phase 2 Atopic Dermatitis Trial
CompanyDrug

Lynk’s LNK01004 Pan-JAK Inhibitor Shows EASI-75 Win in Phase 2 Atopic Dermatitis Trial

Acotec's Jingyi Balloon Catheter Wins NMPA Approval for Complex Coronary Lesions
CompanyMedical Device

Acotec’s Jingyi Balloon Catheter Wins NMPA Approval for Complex Coronary Lesions

Sino Biopharm's LM-350 CDH17-ADC Wins NMPA Nod for Clinical Trials
CompanyDrug

Sino Biopharm’s LM-350 CDH17-ADC Wins NMPA Nod for Clinical Trials

Cutia's CU-40105 Topical Finasteride Spray NDA Accepted by NMPA, a China First
CompanyDrug

Cutia’s CU-40105 Topical Finasteride Spray NDA Accepted by NMPA, a China First

Mirxes and Walvax Form RNA Partnership for Vaccines and Precision Medicine
CompanyDeals

Mirxes and Walvax Form RNA Partnership for Vaccines and Precision Medicine

NMPA Releases 98th RLD Catalog for Chemical Generics, Adding 48 New Specifications
Policy / Regulatory

NMPA Releases 98th RLD Catalog for Chemical Generics, Adding 48 New Specifications

Roche's Lunsumio SC Wins EU Conditional Approval for Follicular Lymphoma
CompanyDrug

Roche’s Lunsumio SC Wins EU Conditional Approval for Follicular Lymphoma

Roche's giredestrant SERD Achieves iDFS Win in Phase 3 lidERA Breast Cancer Trial
CompanyDrug

Roche’s giredestrant SERD Achieves iDFS Win in Phase 3 lidERA Breast Cancer Trial

Hengrui's HRS-6209 CDK4 Inhibitor Wins NMPA Nod for Breast Cancer Combo Trial
CompanyDrug

Hengrui’s HRS-6209 CDK4 Inhibitor Wins NMPA Nod for Breast Cancer Combo Trial